As OpenAI eyes a public offering, discussions with Microsoft focus on future technology access and investment structures.

OpenAI has reportedly met with officials from the U.S. Food and Drug Administration (FDA) to discuss the use of artificial ...

The AI startup says it will change its for-profit subsidiary into a public-benefit corporation, following controversy over ...

OpenAI’s $3B Windsurf acquisition reshapes AI innovation, challenging Google and Anthropic in the race for artificial ...

The FDA has started exploring how AI can be used to accelerate drug approvals in collaboration with OpenAI amid oversight ...

OpenAI CEO Sam Altman will testify before the Senate Committee on Commerce, Science, and Transportation Thursday about the ...

OpenAI abandoned its effort to shift to a for-profit corporate structure, instead opting for a public benefit corporation ...

OpenAI and Microsoft Corp. are revising the terms of their partnership that will enable the ChatGPT maker to go public at a ...

OpenAI and Microsoft are rewriting the terms of their multibillion-dollar partnership in a high-stakes negotiation designed to allow the ChatGPT maker to launch a future IPO, while ...

OpenAI is reversing course and said Monday its nonprofit will continue to control the business that makes ChatGPT and other ...

OpenAI plans to invest in efforts outside of the US to develop the infrastructure necessary to run artificial intelligence ...

OpenAI is reversing course and said Monday its nonprofit will continue to control the business that makes ChatGPT and other ...